Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Inflammatory Bowel Diseases

Free Subscription 28.01.2019 2 Aliment Pharmacol Ther 1 Am J Gastroenterol 1 BMC Gastroenterol 2 Dig Dis Sci 1 Eur J Gastroenterol Hepatol 2 Gastroenterology 2 Gut 3 Inflamm Bowel Dis 1 J Crohns Colitis 1 Mediators Inflamm 1 Scand J Gastroenterol 1 Z Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Aliment Pharmacol Ther

1. OSTERMAN MT, Rosario M, Lasch K, Barocas M, et al
   Vedolizumab exposure levels and clinical outcomes in ulcerative colitis: determining the potential for dose optimisation.
   Aliment Pharmacol Ther. 2019 Jan 20. doi: 10.1111/apt.15113.
   PubMed     Text format     Abstract available
   
   
2. AGRAWAL M, Cohen-Mekelburg S, Kayal M, Axelrad J, et al
   Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factors.
   Aliment Pharmacol Ther. 2019 Jan 20. doi: 10.1111/apt.15107.
   PubMed     Text format     Abstract available
   
   

   
   Am J Gastroenterol

3. ZHAO S, Wang J, Zhao Z
   Inflammatory Bowel Disease and Risk of Erectile Dysfunction: What Does the Current Evidence Tell Us?
   Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000070.
   PubMed     Text format    
   
   

   
   BMC Gastroenterol

4. MURTHY SK, Shukla T, Antonova L, Belair MA, et al
   Predictive models of disease burden at diagnosis in persons with adult-onset ulcerative colitis using health administrative data.
   BMC Gastroenterol. 2019;19:13.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis Sci

5. FIELDS AC, Melnitchouk N
   Medical Prophylaxis of Post-Surgical Crohn's Disease Recurrence: Towards Timely Anti-TNF Therapy.
   Dig Dis Sci. 2019;64:7-8.
   PubMed     Text format    
   
   
6. AMORIM RF, Viegas ERC, Carneiro AJV, Esberard BC, et al
   Superiority of Interferon Gamma Assay Over Tuberculin Skin Test for Latent Tuberculosis in Inflammatory Bowel Disease Patients in Brazil.
   Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5475.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

7. LIEFFERINCKX C, Minsart C, Cremer A, Amininejad L, et al
   Early vedolizumab trough levels at induction in inflammatory bowel disease patients with treatment failure during maintenance.
   Eur J Gastroenterol Hepatol. 2019 Jan 21. doi: 10.1097/MEG.0000000000001356.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterology

8. 
   Management of Mild-to-Moderate Ulcerative Colitis: Patient Guide.
   Gastroenterology. 2019 Jan 19. pii: S0016-5085(19)30096.
   PubMed     Text format    
   
   
9. MAHADEVAN U, Robinson C, Bernasko N, Boland B, et al
   Inflammatory Bowel Disease (IBD) in Pregnancy Clinical Care Pathway - A Report from the American Gastroenterological Association IBD Parenthood Project Working Group.
   Gastroenterology. 2019 Jan 16. pii: S0016-5085(18)35437.
   PubMed     Text format    
   
   

   
   Gut

10. LEVINE A, Kori M, Kierkus J, Sigall Boneh R, et al
    Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial.
    Gut. 2019;68:239-247.
    PubMed     Text format     Abstract available
    
    
11. SAHNAN K, Tozer PJ, Adegbola SO, Lee MJ, et al
    Developing a core outcome set for fistulising perianal Crohn's disease.
    Gut. 2019;68:226-238.
    PubMed     Text format     Abstract available
    
    

    
    Inflamm Bowel Dis

12. FUKAURA K, Iboshi Y, Ogino H, Ihara E, et al
    Mucosal Profiles of Immune Molecules Related to T Helper and Regulatory T Cells Predict Future Relapse in Patients With Quiescent Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Dec 20. pii: 5298886. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
13. KANE S
    Letter to the Editor: Missed Meals While Hospitalized for UC.
    Inflamm Bowel Dis. 2018;24:660.
    PubMed     Text format    
    
    
14. FUHLER GM, van der Giessen J, van der Woude CJ, Peppelenbosch MP, et al
    Correlating Fecal Calprotectin With Hemoglobin Levels Within 1 Sample.
    Inflamm Bowel Dis. 2018;24:663.
    PubMed     Text format    
    
    

    
    J Crohns Colitis

15. ZABANA Y, Rodriguez L, Lobaton T, Gordillo J, et al
    Relevant infections in inflammatory bowel disease, their relationship with immunosuppressive therapy and their effects on disease mortality.
    J Crohns Colitis. 2019 Jan 18. pii: 5298189. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Mediators Inflamm

16. OZ HS, Yeh SL, Amedei A
    Gut Inflammatory Diseases, Infection, and Nutrition.
    Mediators Inflamm. 2018;2018:7160859.
    PubMed     Text format    
    
    

    
    Scand J Gastroenterol

17. PROUDFOOT H, Norton C, Artom M, Didymus E, et al
    Targets for interventions for faecal incontinence in inflammatory bowel disease: a systematic review.
    Scand J Gastroenterol. 2018;53:1476-1483.
    PubMed     Text format     Abstract available
    
    

    
    Z Gastroenterol

18. 
    Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS).
    Z Gastroenterol. 2019 Jan 17. doi: 10.1055/a-0824-0861.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: